AFP and hepatocellular carcinoma: We constructed two different HCC tissue-specific RNAi systems in which therapeutic miRNA or shRNA against target gene (Beclin 1) was directly or indirectly driven by an AFP promoter (AFP-miRNA system and AFP-Cre/LoxP-shRNA system).